Aaditya joined Sofinnova BioEquities in 2020 as an Analyst and was promoted to Senior Analyst in 2022. He focuses on public investments in global biotech and pharmaceutical companies.
Prior to Sofinnova, Aaditya was a Senior Associate at Foresite Capital focused on public and private investments in commercial-stage companies across healthcare. Before Foresite, Aaditya was a Senior Associate at Citadel Global Equities covering therapeutics. He began his career as an Analyst on the Healthcare Mergers & Acquisitions and Corporate Advisory team at Centerview Partners.
Aaditya received his M.S.E. and B.S.E. in Bioengineering along with a B.A. in Economics from the University of Pennsylvania.